🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Influenza virus is a significant pathogen in pediatric solid organ transpla...
Status
Recruiting
Location
Stanford University
Start Date
2024-09-26
Trial ID
NCT05947071
Lung allograft recipients have a higher burden of influenza disease and gre...
Status
Recruiting
Location
Vanderbilt University Medical Center
Start Date
2022-11-08
Trial ID
NCT05215327
This EPSS will determine the vaccinee reporting rates (RRs) of suspected AD...
Status
Completed
Location
Investigational Site Number : 2460001
Start Date
2023-10-02
Trial ID
NCT06059456
Treatments Being Tested
The main purpose of this Phase II study was to assess the safety and immuno...
Status
Completed
Location
Investigational Site Number :8400003
Start Date
2021-07-16
Trial ID
NCT04969276
Treatments Being Tested
The aim of the study is to evaluate the safety and immunogenicity of the 20...
Status
Completed
Location
Multiple Locations
Start Date
2015-09
Trial ID
NCT02563093
This prespecified analysis will pool the datasets from two pragmatic random...
Status
Completed
Location
Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte
Start Date
2025-05-31
Trial ID
NCT06506812
Treatments Being Tested
The primary objective of the study was to provide sera (collected from part...
Status
Completed
Location
Investigational Site Number 8400002
Start Date
2019-09-30
Trial ID
NCT04109222
Primary Objective: To demonstrate the superior relative effectiveness of Q...
Status
Terminated
Location
Investigational Site Number 2469999
Start Date
2019-11-04
Trial ID
NCT04137887
The primary objective of the study is to estimate the reporting rate of sus...
Status
Completed
Location
Investigational Site Number :2-2-002
Start Date
2021-10-12
Trial ID
NCT05078060
Treatments Being Tested
This is a multiple sites phase II trial, randomized, observer-blind, dose r...
Status
Completed
Location
MUHC-Vaccine Study Centre
Start Date
2014-07-16
Trial ID
NCT02236052